Showing results (791-800 of 14,088) with videos related to
Sort By:
Pageof 1,409
Gynecologic Oncology|June 27, 2019
Awareness and acceptability of population-based screening for pathogenic BRCA variants: Do race and ethnicity matter?Lisa A Rubinsak, Annette Kleinman, John Quillin, et al.Gynecologic Oncology|October 14, 2019
Secondary cytoreductive surgery in platinum-sensitive recurrent ovarian cancer before olaparib maintenance: Still getting any benefit? A case-control studyC Marchetti, A Rosati, G Scaletta, et al.Gynecologic Oncology|September 1, 1985
Plasminogen activator activity in human endometrial carcinomaC W Whitney, P G Satyaswaroop, R MortelGynecologic Oncology|January 1, 1986
A pilot study of high dose abdominopelvic radiotherapy following surgery and chemotherapy for stage III epithelial carcinoma of the ovaryR S Coltart, A B Nethersell, C H BrownGynecologic Oncology|February 4, 2022
Understanding cervical cancer after the age of routine screening: Characteristics of cases, treatment, and survival in the United StatesKatie E Lichter, Kimberly Levinson, Anne Hammer, et al.Gynecologic Oncology|February 14, 2022
Clinical characteristics and thyroid function in complete hydatidiform mole complicated by hyperthyroidismMarcos Montanha Ramos, Izildinha Maesta, Roberto Antonio de Araújo Costa, et al.Gynecologic Oncology|November 3, 2021
Sentinel lymph node biopsy for stage II endometrial cancer: Recent utilization and outcome in the United StatesKoji Matsuo, Maximilian Klar, Varun U Khetan, et al.Gynecologic Oncology|January 22, 2022
Olaparib maintenance monotherapy in platinum-sensitive relapsed ovarian cancer patients without a germline BRCA1/BRCA2 mutation: OPINION primary analysisA Poveda, S Lheureux, N Colombo, et al.Gynecologic Oncology|January 22, 2022
Clear cell carcinoma of the endometriumGiorgio Bogani, Isabelle Ray-Coquard, Nicole Concin, et al.Gynecologic Oncology|January 22, 2022
Randomized phase II trial of weekly paclitaxel vs. cediranib-olaparib (continuous or intermittent schedule) in platinum-resistant high-grade epithelial ovarian cancerNicoletta Colombo, Federica Tomao, Pierluigi Benedetti Panici, et al.Pageof 1,409